Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer

NCT00488982 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00488982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
May 31, 2014
Enrollment
125 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer